IMPORT UNREGISTERED DRUGS THROUGH NAMED PATIENT PROGRAMMES
NAMED PATIENT PROGRAMMES
At COREX, we deliver potentially lifesaving treatments to patients worldwide through the ‘Named Patient Programme’.
In different countries such programmes have different names — Expanded Access in the US and Special Access Scheme in Canada. The UK uses EAMS — Early Access Medicines Schemes, known as Compassionate Use in Germany — whatever the variation on the title, they all mean the same thing. Hope.
Our expert team handles all regulatory issues with in-depth knowledge and invaluable local insight
From import licence submission, through customs clearance, spe- cialist transportation through to distribution, COREX takes care of the supply chain from start to finish.
More than a thousand patients have received vital medications for the treatment of diseases.
A global network of Approved Suppliers
Accelerated customs clearance (no more than 24 hours)
We work with Clinical Trial Organisations and Healthcare Providers to access and supply potentially life-changing medicines and treatments, and provide practical care and supporting patients and families with tailored solutions.